Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. Transcript, audio stay in one workspace.
Conference · 2026-09-17
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Executive readout · one minute
Read the call alongside every captured source. Transcript, audio stay in one workspace.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Open the source you need; every reader stays inside this workspace.
All right, good morning, everyone. My name is Brandon Knudsen. I am on the multi-industrials research team here at Morgan Stanley, and today I have the pleasure of speaking with Vicente Renal, Chairman, President, and CEO of Ingersoll Rand, and Vic Kinney, CFO of Ingersoll Rand. Before we get started, I have to read some disclosure announcements. So for important disclosures, please see the Morgan Stanley Research Disclosure website at morganstanley.com slash research disclosures. If you have any questions, please reach out to your Morgan Stanley representative. All right. So, Vicente, a lot of industrial companies are describing improvement, but your short cycle and medium cycle businesses were already kind of growing mid-single digits. What are you seeing as the clearest evidence that the cycle is broadening?
Yeah. So, I'll say, you know, the first quarter, you saw that organic revenues, we were down about 1% and Q2 moved into positive mid-single digits around 4% organic revenue growth. And then we We also, on the last earnings call, we gave a bit of a caller into the July number, something typically that we don't tend to do, but it was just to kind of talk about that not only the short-cycle businesses was picking up, but also that long-cycle business we're starting to see. And I think the importance there is that it was not a one-time event. It was not a one-time single project. It was not an easy comp. And it was fairly broad-based in terms of end markets and regional side. So I think we sit here fairly optimistic. is what we're seeing. We also feel that this is not just some of the market moving, but the investments that we have done over the past 12 to 18 months on the organic side, whether it is feet on the street, new facilities. Around this time last year, we were celebrating an opening of our new facility in Latin America and Brazil, where we can actually localize technologies. We also expanded our compressor facility in India after continuing to see phenomenal double-digit growth in India. So I think a lot of these investments are kind of paying off as we see here moving forward.
That's great. And regionally, America appears to be strongest today while Europe has been more mixed. What do you think is driving that divergence, and do you see any change on the ground there?
Yeah, I'll say over the past couple of years, a few years, is the European business has been the most, I'll say, stable, albeit not growing, but kind of fairly stable. And if you remember, we spoke about the North America business seeing a bit of a headwind about 12 to 18 months ago when renewable natural gas was kind of peaking around late 24, early 25 in terms of orders and then basically coming out to almost zero. And then we're just kind of offsetting that. Offsetting that, but also seeing general manufacturing, food and beverage, PowerGen, some of the kind of more general industrial end markets, seeing better momentum, and obviously leading to what we saw in the second quarter, which it was basically high single-digit organic order momentum in the American's business.
And how much of this recent growth would you say is under market strength versus Ingersoll-driven share gain and commercial execution?
It's a little bit of both. It's kind of what we like to say. Part PMIs, as we all know, they turn to be above 50 in January. And we always say that ITS business in particular takes about a couple quarters to see the turn, and that's kind of what you kind of saw here in the second quarter. So there's a little bit of that market tailwind that is happening. But again, I go back to and make reference to the comment that I made on the investments that we have done. Another investment that we have done that we're putting a lot of effort into it over the past 12, 13 months that we expect to see benefit of that is our engineered to order solution. So if you think about as a company, we tend to be very decentralized and we operate in individual P&Ls. We have two segments, but there's like nine P&Ls that report directly into me. and we launched an initiative on applying some vertical market approach for creating solutions. So whether it would be wastewater facilities or things of that nature where we can take technologies from both ITS and PST, combine them and be able to provide a very unique solution to the customer. Or kind of working with specific end users that may want to take the same approach in a more modularized approach where we can take a kit with multiple technologies and then provide that to the customer so it facilitates the installation at the site. And I think a lot of those solutions is something that we have been doing a lot of investments. We have manufacturing locations across the world that are dedicated to this. We have engineers globally that are dedicated to this. And we think that this is going to be a good outcome for Ingersoll Brand moving forward, be able to provide these solutions that combined with a little bit of a tailwind in the market could accelerate how we view things organically.
And you see that as coming through a little bit in the second quarter, but really the tail in return on that investment should be over the next 12 months or so.
That's our view.
Great. So you mentioned July having strong inflection in orders. You talked about it on the Q2 call. Should investors see that as a true beginning of the trend, or is it timing of large projects or maybe related to getting ahead of price increases? Anything there?
Yeah, no, I think we're very encouraged by what we saw in July. you know, to Vicente's point, it's not our norm to give, like, an inter-quarter orders update, but we thought it was important to give a little bit of color on what we saw in July. We had the benefit of sitting at the end of July. We had kind of the first four weeks of July behind us. Excuse me. And what we said was that orders in the ITS side of the equation was up mid-teens. And the way to kind of think about that is, I'd say, comparable momentum on the short to medium cycle is what you saw in Q2. But obviously kind of the kicker, for lack of a better way to say this, or kind of the outpaced growth was driven a lot by the long cycle side of the equation. We've described our portfolio that in ITS, about 40% of our business is aftermarket. And then when you look at the original equipment, about 75% is short to medium cycle, 25% behaves more long cycle. Those long cycle are those kind of larger projects that really inherently exist across, I'd really say our entire portfolio, compressor, blow, or vacuum even pumps. And they're pretty widespread from a geographic perspective. So there isn't really a huge concentration in one region versus another, pretty widespread. And that's exactly what we saw in July. In July, we saw a number of those larger projects that we had been talking about being in the funnel, the long cycle funnel over the last couple of years, being active and healthy. But we would acknowledge you'd seen kind of an elongation in terms of decision making, kind of those POs getting to the finish line. And what you saw in July was a number of those kind of normal course, longer cycle projects across a wide variety of end markets kind of finally getting to that PO stage. And so the way we describe it here is very encouraged, obviously, by what we're seeing. You know, obviously, we don't view it as some, like, big flush of the funnel or anything like that. The quoting activity has been quite healthy and active in terms of kind of replenishment and continuation of that funnel. And so, you know, I think, you know, obviously, one month is just one data point. But I think we remain very encouraged by, you know, now starting to see the short to medium cycle kind of momentum that we've been talking about for a few quarters. and now for the first time in quite a while seeing the long cycle also starting to see some traction on top. So it's the first time in, frankly, the better part of the last two years where you've kind of now seen not just organic volume starting to come back in a more meaningful manner, but also seeing contributions kind of from both sides of the original equipment portfolio.
Okay, and you made it clear that those projects were being delayed and unnecessarily canceled, and now it's coming through in July and proving that out. Are you still seeing customer willingness to commit to these long cycle CapEx projects improving, or is it more like elongated cycles, essentially?
No, we see, I mean, the momentum on that continues to, I'll say, increase. I mean, the funnel continues to grow. We continue to see investments, whether some of those could be related to near shoring, could it be to some of the semiconductor exposure. You know, we still believe that there's more to come around maybe rebuilding some of the things that are happening in the Middle East and things of that nature. So I think we continue to expect to see some of these kind of longer cycle projects to continue.
That's great. Is there any market that dominates the long cycle pipeline? You've talked about food and beverage, pharma, PowerGen. But anyone that kind of dominates and anyone that can become disproportionately large in that pipeline?
No, I wouldn't say there's anyone that dominates it. To your point, and I think the point, we have long cycle exposure across, like I said, most of our product technologies. And by definition, it means it's quite globally spread. So to your point, whether it be infrastructure, power gen, air separation, water, wastewater, food and beverage, you've seen a number of different outlets and avenues. Now, to your point, yeah, historically, just based on maybe regional trends and things like that, you have seen certain end markets be able to show disproportionate growth. That's why you've seen things like, for example, in the 22, 23 timeframe, you saw EV batteries in China, which lends itself to some of our long cycle equipment there, or RNG in the U.S., which lends itself to some of our gas compression technology. But I think, you know, overall, longer-term kind of duration and horizon, no, nothing that we'd say is disproportionately larger plays pretty well across some variety of head markets.
Great. I want to shift gears a little bit to AI and data centers. Obviously, the big theme within industrial is driving a lot of activity, but investors don't typically think of Ingersoll as primarily a beneficiary of data center. Where exactly do compressors, vacuums, blowers, et cetera, participate in the AI infrastructure space?
Yeah, so it's an interesting one. I mean, because the software has been definitely minimal. I will say that, but we believe that we have the right to play in some places. And that's kind of back to the commentary that I made about these engineered-to-order solutions and how we can combine different technologies, provide modularized technologies that could actually be collocated within a specific environment and provide the easiness of kind of plug-and-play versus kind of what we're seeing is kind of getting done out there. So still early days, early stages for us to kind of participate pronouncedly. I mean, we think that there is an avenue for us to play there, and we'll see more as we kind of move forward here in the future. And whether it could be working with hyperscalers or collocators and things of that nature. In addition to that, I mean, obviously, there's secondary activities, second-degree attachment to the AI and data center boom, whether it could be the semiconductor expansion, and that, of course, we play. We're one of the market leaders in working with some of the gas companies on compressors for air separation. A lot of these facilities, they have also wastewater facilities and kind of need some of that as well, which we can do. So there's some secondary, but, I mean, I think in the first degree on how do we get closer, we have been doing a lot of voice of customer, a lot of understanding, a lot of visits to data centers to see how can we, with our engineer-to-order solutions, we can improve the way things are done, and I think there's some potential avenues there.
Now that you've been in the market for more time with these engineer-to-order solutions, are you starting to see real traction with data center infrastructure builders?
We're definitely having conversations, which is good.
Early days.
The doors are not getting closed.
Right. Okay. Sounds good. Switching a little bit to aftermarket that represents about a little over a third of the business. How quickly does aftermarket grow when equipment sales accelerate? Like, what's the timeline for that flipping?
Yeah, so typically, I mean, I think what you're seeing here is that aftermarket has percentage of sales, you know, kind of high 30s, you know, call it rounded up to 40. We have aspirations for that to continue to grow, you know, and, you know, over time, you're seeing the absolute dollar of aftermarket grow. I mean, clearly the OE is also growing, so that's why the percentage continues to stay in that kind of level. but typically to your point we start seeing right almost at the time that you install the equipment you see some aftermarket consumables because in order to maintain the warranty you have to use a lot of the consumables in many cases to ensure the proper efficiency of the compressor as an example and then from there after warranty more service and solutions we have said a lot about that we're moving to a model where we can get a customer, you know, in an agreement for five or ten years that provides a bit more benefit for them to be a much more sustainable OPEX line for them while we have the capability of connecting the compressor or the asset and be able to remote monitorly, remote do preamps, and be able to send service technicians for the right procedure that needs to happen if something were to fail. But, you know, you could argue that aftermarket, you know, six months into the installation starts to come in the consumable and starts to ramp kind of sustainably from there.
Is there any application or product set where that service opportunity isn't there? Or is it the whole portfolio is an opportunity essentially on new equipment to add service on top of it?
We view it as everything that we have in the portfolio has an opportunity to create aftermarket, and even including on some of the technology that we have in our life sciences solution. So we do, for example, a lot of the robotic automation for liquid handling. There's an opportunity as well for having a service solution and aftermarket on that.
That's great. I want to shift a little bit to M&A. That's a big part of the growth algorithm. You're all shown to be great compounders and really disciplined on M&A that you do. So you walked away from approximately a billion of potential transactions recently because valuations just seemed a little too rich. Has the broader M&A market become more or less attractive in your view?
So I would say that we have, I think in the last earnings call, we said that we have roughly 200 companies in the funnel. We still have that or more, 11 companies on their LOI, letter of intent, and that letter of intent typically is a very high percentage likelihood that it will get into a closing of the transaction. So we'll continue to be very, very pleased with the flywheel that we have in the Bolton M&A and that we do it in a very disciplined fashion. If you look at the aggregate companies that we acquired in 2025, low single-digit multiple, I mean, nine and a half times, pre-synergy, and one that we believe we can kind of take down three or four turns on a post-synergy multiple on things that we can control, So SG&A, direct materials, pricing efforts, and things of that nature. From time to time, we then see some larger transactions. I mean, but we remain very disciplined. So these larger transactions, basically one of them, we never saw. I mean, you've got to be careful now because, I mean, some companies are seeing some of that second degree of AI or data center exposure. And you've got to be careful because you get a discount that eventually is going to come down, I guess. So I think we just remain very disciplined on how we look at the companies on a financial performance perspective.
And when you're looking at these acquisition targets, how important is increasing aftermarket content when you're evaluating opportunities?
It is important. I mean, it is definitely one of the, it is not the sole factor that we look at, but we always like to say that we're looking for companies that have a good gross margin that we can actually expand in companies that have a level of aftermarket that we can see that we can improve. And so aftermarket continues to be a factor on that decision-making.
Is there any reason Ingersoll needs to do another large platform acquisition, or are there enough opportunities on the bolt-on side to deliver the inorganic growth that you need?
Plenty of opportunities at this point in time. So we don't see the need to do a transformational acquisition. I mean, obviously, we continue to execute on this bolt-on strategy that we have. From time to time, we continue to look and understand is there anything out there that could be transformational in nature. But for that, it has to be something very unique and very special that will give us the ambition to do it. But for now, we remain disciplined on our bolt-on strategy and we'll continue to observe. And if we see anything that could be transformational in nature, we can do it. We have the financial power and the liquidity to be able to do it when we're only 1.7 times lever and roughly $4 billion on liquidity. So we have the capability and the capacity, but we're going to continue to remain disciplined.
And what do you see as kind of how high you would go leverage-wise in order to do a large deal if something became attractive and available?
Yeah, I mean, I think we want to stay prudent. We've always said that we want to long-term keep profile leverage sub two times. Now, to that point, if there's something that is, quote unquote transformational of nature that we feel like is a great fit. The concept of going to arguably over three times leverage but then having an imminent path back to that sub two times leverage in a relatively short time frame. Sure, that's something we'll evaluate. But to Vicente's point, we're going to continue to be prudent and patient. Just to give it a little color, all of the deals that we talked about under LOI are up to smaller bolt-on variety, very similar to what you've seen us execute on over the last six to 18 months. So I don't think anything has been changed in that perspective in terms of being disciplined and prudent.
Great. I want to pivot to China a little bit. So there's been a drag on ITS margins recently because inflation has been difficult to recover through pricing. Why has pricing been more difficult in China than the rest of the world?
Yeah, maybe I'll start there, maybe give a little bit of color here. So as far as the margin profile, and I'll kind of weave this in with the pricing question, I think historically speaking, if you were to go back two, three, four, five years ago, So China or Asia-Pacific as a percentage of our overall revenue was closer to 20%. China was about 15% off that 20%. So it was the lion's share of our Asia-Pacific portfolio. For the factors that Vicente mentioned, you know, back into kind of really exiting the 23-24 time frame, you know, the big run-up you'd seen in things like EV batteries kind of came back down. And then, frankly, just the overall China market reset that you've seen. China is now closer to about 10% off our revenue profile, whereas Asia-Pacific is about 15%. So obviously, China has kind of reset, for lack of a better way to say this, within the overall kind of portfolio. And so a couple of things that you've seen over the last few years. One, obviously, as you've seen that reset, first and foremost, our Asia-Pacific business is a profitable region. And obviously, when you've seen that kind of volume reset, you have seen some headwinds on the margin front compared to where we were a few years ago, largely attributable to that kind of volume kind of component. As far as the pricing side of the equation is concerned, you know, a couple of comments. We did indicate that in Q2, you saw China was about a negative low single-digit headwind to pricing. So total ITS is delivering between 1% to 2% price with that negative low single-digit from China. Now, if you go back in time, China really never has played at the same levels of pricing as North America or Western Europe. Think of it as being more flattish. So yeah, maybe there's a couple hundred basis point headwind to that, which I think is just a reflection of the overall market, at some of the overcapacitization you've seen in the overall environment, not necessarily just our equipment, but kind of broader speaking. And so for our perspective here, what's encouraging is starting to see some of that China volume starting to come back, right? So even in Q2, we indicated that China was actually up low double digits, inclusive of that pricing headwind, which means volume was probably up more like mid-teens. So I think as we continue to see, I'd say better stability and traction in China, more medium term, we would expect to see pricing get nominally a little bit better. We're not expecting China pricing to get positive necessarily or back to the levels of North America or Europe. But closer to that flattish realm over the medium term, I think, is more the expectation. It's just going to take a little bit of time.
And what needs to happen there? Because you said volumes are already coming back, but pricing hasn't. What else needs to happen besides volumes in order for pricing to normalize?
Yeah, I think it's just a little bit of time and normalization. We've been through a couple years of that entire market getting reset. So one quarter or two quarters is not going to necessarily, you know, be the inflection point. It's going to take a little bit more time for stabilization. But I think to your point, the good news is, you know, we see encouraging trends at least just, you know, in terms of how some of the broader market dynamics are playing out there. We saw it in Q2. And I think the other piece here is if you look kind of under the covers of our China business, again, not all products are necessarily made equal in the context of pricing, right? We are seeing positive pricing in certain areas like aftermarket and maybe some of the more differentiated newer products that we've brought to that market over the course of the last few years like blower and vacuum and air treatment as well as some of the localized product that we've brought from some of the bolt-on acquisitions. So, again, I think we're going to continue to obviously manage it in a kind of a portfolio-wide approach, but it's just going to take time is kind of the basic thing.
And if we get a few more quarters of China volumes increasing, do you have a sense for how long it usually takes for that price environment to normalize? Is it a 12-month phenomenon, 18, 6?
Yeah, tough to say exactly the right time frame here, but I think your point is valid here. If we continue to see better traction on the volume side, we would expect things will start to settle down a little bit, and then we can start kind of closing some of that, narrowing some of that gap we see on the pricing side between where we are today and more of that flattish level.
And would you ever choose to exit kind of lower differentiation product categories where pricing is structurally unattractive rather than just chasing the volume that comes with it?
I think in our view, when you think about our products, I mean, we tend to be highly differentiated, which is the reason why we continue to maintain a pretty high level of margin and the ability to be able to get that 1% to 2% of price every single year regardless of the market. So I'll say that on purpose we want to take technologies that are differentiated. When you think about it, we're an $8 billion roughly revenue company. We play in a $75 billion addressable market. So plenty of opportunity for us to be selective on technologies that we want to continue to acquire, plenty of opportunities for us to be selective in the end markets that we want to play, and we believe that we can only win as long as we really deliver that total cost of ownership with differentiated solutions.
And then broadening out from China, you gave the July update on the quarterly call, but as you look across the rest of the world, how would you characterize the underlying demand environment today?
Yeah, sure. I'll just keep it relatively simple here. I think North America, obviously, has been seeing the best kind of improvement here. We talked about it in Q2, high single-digit kind of orders improvement. So continuing to encourage what we're seeing in North America, particularly after kind of the last two years that have been a little bit more tougher sliding, for lack of a better way to say it. We talked pretty extensively about China and Asia Pacific just now. Obviously, Europe is the piece, or we run it as EMEA, Europe, Middle East, India, Africa. To Vicente's point from earlier, it's been the most stable region now over the last few years. I think right now it's kind of relatively neutral. Not all parts of EMEA are kind of made equal, for lack of a better way to say that. I think India, for example, has been our best-growing region for probably the last number of years. Clearly, right now, Middle East, obviously, has seen some of the challenges. Central Europe, comparable. Areas like Italy, Spain, you know, have been seeing some pockets of opportunity. So, you know, some puts and takes within, I'd say, the broader EMEA expanse, but when you put it all together, relatively neutral. And then, you know, areas like, you know, we mentioned India, areas like Latin America, areas like Southeast Asia, we've kind of highlighted those as probably three of the four kind of major areas of, we'd say, potential outsized growth, as you think, more medium to longer term. And a lot of that is just because of, you know, we have good presence there. We've been making structural investments, whether it be commercial investments or I think Vicente has mentioned here, you know, we put two new manufacturing plants into operation over the course of last year, one in Latin America for localized compressor manufacturing, a second manufacturing plant in India for compressors because we frankly had run out of capacity in our first one. So those are areas that we see, I'd say, maybe slightly outsized opportunity just because of maybe our historical presence, our share there is not at the same levels as you see in areas like North America and Western Europe. And so, again, continue to be optimistic there in terms of the long-term growth. But, you know, I'd say that's kind of how we're seeing the expanse from North America to Europe to APAC.
Great. And then getting more specific on ITS. We saw organic growth grow 4%-ish in Q2, but EBITDA margins declined year over year. You highlighted China price costs as being a pressure there, but also investments that you're making in new technologies and commercial operations and higher corporate costs. Which one of those reverses the fastest and which one is more of a structural phenomenon?
The fastest is going to be the price cost situation. We spoke about how as we were into last year, because of tariff situation, we were going to do price cost neutral, meaning that increase enough on the price to cover the tariff, but not to kind of get the margin or benefit of that, you know, price on that side. As we kind of move here into the second half, I mean, we're comping some of that. And in addition to that, we have done also incremental pricing that we typically do here in the first half of the year. And so that's going to prove to kind of deliver some better improvement on the price cost The second piece is that, you know, we, as we tend to always optimize the business, we did some restructuring, kind of second, you know, end of Q4, kind of early Q1 roughly, and some of that kind of will see some of the fruit too as well as we kind of come into a second half.
Then you see the long-term ITS earnings power there approaching 30% EBITDA margins. What needs to happen operationally for the segment to get there?
I mean, I think what I say that, you know, it's a segment that we see structurally nothing different than, I mean, it can definitely continue to achieve or will get to that 30%. So structurally, nothing that has dramatically changed, except obviously the tariff situation that has been this kind of price-cost neutral that really affects the margin. So I think, and also in addition to that, you know, you saw, you know, the negative organic volume that clearly that created the headwinds. I mean, despite that, I mean, the segment still trades or still runs at, you know, high 20s, I mean 26, 27% EBITDA margins. So we're in that kind of close into the line that as we continue to now get the price cost equation improvement and as we start to see in the volume, the organic volume, those are going to be the main drivers to kind of get back to those levels.
And then on PST, that continues to be a bright spot, 31.5 margins in Q2, targeting around 32% plus in the second half on a path to mid-30s. What remains the largest lever from here to drive those margins up?
Yeah, I think we're incredibly pleased with the momentum we've seen on the PST side. Just to kind of give a bit of color here, you've got the two platforms within PST. You've got, I'll use rough numbers, roughly a billion dollar precision technologies, kind of niche positive displacement pump business. You've got a $600, $700 million life sciences platform. I think you've seen a lot of efforts over the course of the last few years, particularly on the life sciences side, to further integrate those assets. Obviously, a big piece of that equation is the ILC Dover assets that were acquired two-plus years ago. I think you've seen a lot of the heavy blocking and tackling in terms of the integration, getting those P&L structures set up, managing that P&L and that business in a very comparable manner to how you see the rest of the enterprise, getting things like IRX and I2V and a lot of the kind of internal mechanisms and playbooks into that business. So at this point in time, to your point, you're seeing good growth across both. You know, the PT business tends to be a little bit shorter cycle in nature. So by definition, you've seen that card to come back a little bit sooner just based on some of the short to medium cycle momentum you're seeing, broader speaking. And then obviously the life sciences business has been, frankly, the best growth business of the entire portfolio. So I think on the go forward piece here, to your point, now you've seen EBITDA margins sustainably over that 30%, 31% level for approximately four quarters now. The concept of getting that mid-30s EBITDA margin profile not that kind of far away. I think the single biggest catalyst, a number of the same blocking and tackling drivers you would expect to see across the portfolio, but obviously I think the biggest area there continues to be just the growth side of the equation. This is a healthy margin business, plays in the mid-40s, gross margin profile. So just continuing to see, I'd say, the requisite growth on both the PT, but as well as the life sciences business, I think will continue to drive good momentum there.
Great. I want to shift a little more to pricing and margin recovery in the back half. How much confidence do you have that this price realization catches up with inflation without compromising order growth?
Yeah, I think we've been very, I think, prudent and thoughtful about that in the context of making sure that, of course, we're taking the requisite pricing actions, as you would expect. We have nine P&Ls that make up the entire portfolio. Each of our P&Ls does pricing on their own cadence based on the regions, the product lines. In certain cases, there's multiple pricing actions taken through the years based on kind of what needs to be done. And as you can expect, there have been pricing actions that were taken both in the second quarter as well as actually actions that are taking place as we speak here right now. So whether it be just normal course pricing to the question, whether there be some inflationary pressures where we may have to recalibrate a little bit, listen, the teams have gotten pretty adept at having to kind of look at this and reanalyze on a fairly consistent basis just based on what you've seen over the last couple of years with supply chain disruption, tariffs, things of that nature. So I think that is what you should expect to continue to see. I think we're going to continue to remain very prudent and disciplined in the context of where we take price and how we kind of calibrate. To your point, the organic volume piece of the equation is very important. We've seen that coming back nicely here in second quarter. We continue to expect that to kind of keep coming through in the back half of the year. So I think we want to be thoughtful about, you know, maintaining that price and volume kind of balance, along with kind of just some of the other self-help to Vicente's point, things like some of the restructuring actions we've taken, which should be a little bit more visible in the back half, as well as just the direct material productivity equation. And obviously, you know, when you think about the seasonality in ITS, typically speaking, Q1 is your kind of lightest quarter, Q4 is your heaviest with Q2, Q3 in between, and your direct material productivity follows your cost of goods sold. So inherently, as you have more of your shipments in the back half of the year, you typically tend to see that margin profile follow. So I don't think this year should be any different than that expectation in terms of just the sequential momentum you would see from the first half into the back half.
That makes sense. And you mentioned earlier that outside of China, pricing is relatively normal at 1% to 2%. Is that what we should think about as a through-cycle pricing contribution, or is there anything that's changed in Ingersoll to make that higher?
Nothing has changed. I mean, clearly we're going to try to always push it, be higher than that, but I think you can think about it always as that, 1% to 2% of price through the cycle in any environment.
And the second half, margin ramp depends on things we've talked about in terms of pricing, normalized corporate costs, productivity. Which of those carries the greatest execution risk in your view?
Sure. Let me just kind of state, you have improving volume. You've got some of the pricing actions that we've taken that should kind of materialize more in the back half of the year. We did talk about some of the outsized impact for some of those targeted wins we had, for example, in China and Q2 that shouldn't repeat themselves to the same magnitude, as well as some of the productivity factors. I think when we think about, to your question, what carries the most risk, listen, we feel good about the ability to execute across the balance. Obviously, there's some of those that are a little bit more within our control. Some are a little bit more just execution-based, based on the macro environment. But to that point, I think we feel pretty good about where we're continuing to see order trends and things like that. So inherently, obviously, some of the areas that are a little bit more market and execution-driven probably carry a little bit more risk. But those are things that we feel like are manageable. and clearly we're continuing to execute here as we exit through this Q3 and into the back half of the year.
Great, and then looking a little longer term, you've continued to reference roughly 30% ITS and mid-30s PST margin potential. What is the realistic timeline for getting both of those businesses near those levels simultaneously?
Yeah, obviously the timing here, let's just, I think, without putting an exact pin on it here, PST, you know, it's your point, we're approaching that 32% margin range, So I think the concept of getting to the mid-30s, whether you want to define that as 33 or better, you're not that far removed, to be honest. I think on the ITS side, listen, we've been close to that 30%, if not the 30% level before. To your point, obviously, we're stabilizing now a little bit more in that 27%, 28% realm here as we exit the year. I think the concept of triple-digit margin expansion, like you saw back in the days post the merger, I don't think that's the realistic expectation when we go forward. But I think getting back to some requisite amount of margin expansion here in the context of next year, assuming we kind of have a bit of a more normalized growth environment with contributions for both price and volume, I think getting back on track with some degree of margin expansion here in ITS, of course, is the expectation. And as such, more of a medium-term approach in terms of getting back to those levels. It's not going to happen overnight. But to Vicente's point earlier, we don't see any reason why structurally we can't get back to those levels. It's just going to take a little bit of time.
Great. And then thinking about the puts and takes as we start to look towards 2027 and beyond, you've highlighted July strong order growth, general activity going well, investments you're making into growth. Where do we see, in your view, the largest upside to the earnings equation over the next 12 to 18 months?
sure you know i think um you know listen i think i think what we see here is you know clearly as we see here right now we're coming off of a couple years of you know lows for lack of a better way to say this in north america and asia pacific right so i think one those obviously will kind of have hopefully the best ability to kind of rebound here after obviously north america is kind of seeing it in the order profile as we sit here right now i think to vicente's point continuing to leverage some of those differentiated capabilities in terms of eto and things like that showcasing that, which has really become more of something we've been leaning into over the last year, leveraging this kind of one IR portfolio. So for example, we have a strong life sciences presence, about 20%, roughly speaking, if our portfolio is life sciences oriented. But now we really have a true, I'd say, connectivity closer to, you know, with the ILC Dover acquisition to kind of the biopharma, the pharma producers. How can we leverage that to pull through more of the portfolio? So it's really starting to think about that in a little bit of a different manner as opposed to just compressor versus blower versus vacuum? How can we look at things in a much more systematic approach and then leveraging some of our ETO capabilities to really be able to provide differentiated systems and solutions? Obviously, the M&A piece will continue to be there. It's been there. It's going to continue. But I think continuing to think about how we can drive the entire portfolio in a little bit of a differentiated manner is something that we're really leaning into here.
Excellent. Well, thank you both for your time and thank you for coming to the conference.
Appreciate it.
Thank you for the time.
0:00 to 35:20 · One card per analyst, follow-ups included. Each plays from its start, and the one being answered is marked.
All right, good morning, everyone. My name is Brandon Knudsen. I am on the multi-industrials research team here at Morgan Stanley, and today I have the pleasure of speaking with Vicente Renal, Chairman, President, and CEO of Ingersoll Rand, and Vic Kinney, CFO of Ingersoll Rand. Before we get started, I have to read…
Vicente Reynal: Yeah. So, I'll say, you know, the first quarter, you saw that organic revenues, we were down about 1% and Q2 moved into positive mid-single digits around 4% organic revenue growth. And then we We also, on the last earnings call, we gave a bit of a caller into…
Also speaking: Vic Kinney